Vedolizumab (subcutaneous)

vedolizumab · Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vedolizumab (subcutaneous), covering 2025-04-03 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease [Phase 3]

See pricing